Amidepsine D is an inhibitor of diacylglycerol acyltransferase (DGAT). Amidepsine D shows inhibitory effects in rat liver microsomes (IC50=17.5μM) and Raji cells (IC50=2.8μM). Excessive accumulation of triacetylglycerol is produced by DGAT which may cause fatty liver, obesity and hypertriglyceridemia, and may lead to atherosclerosis, diabetes and metabolic disorders.
H. Tomoda, et al.; J. Antibiot. 48, 937 (1995). Tomoda, et al.; J. Antibiot. 48, 942 (1995).
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2021 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.